Altered MT1 and MT2 melatonin receptors expression in the hippocampus of pilocarpine-induced epileptic rats

Publication date: June 2017Source:Epilepsy & Behavior, Volume 71, Part A
Author(s): Anna Karynna Alves de Alencar Rocha, Eliangela de Lima, Fernanda Amaral, Rafael Peres, José Cipolla-Neto, Débora Amado
Clinical and experimental findings show that melatonin may be used as an adjuvant to the treatment of epilepsy-related complications by alleviates sleep disturbances, circadian alterations and attenuates seizures alone or in ...

Seguir leyendo →
0

The efficacy of different kinds of intravenously applied antiepileptic drugs in the treatment of status epilepticus. How can it be determined?

Publication date: June 2017Source:Epilepsy & Behavior, Volume 71, Part A
Author(s): Juliane Redecker, Matthias Wittstock, Johannes Rösche
We explored the influence of four different efficacy criteria on the results of observational studies concerning the treatment of status epilepticus (SE) and its subtypes.We compared and contrasted the results of four different efficacy criteria for the effectiveness of phenytoin, valproate, levetiracetam, and lacosamide. Criterion 1=

Seguir leyendo →
0

The efficacy of different kinds of intravenously applied antiepileptic drugs in the treatment of status epilepticus. How can it be determined?

Publication date: June 2017Source:Epilepsy & Behavior, Volume 71, Part A
Author(s): Juliane Redecker, Matthias Wittstock, Johannes Rösche
We explored the influence of four different efficacy criteria on the results of observational studies concerning the treatment of status epilepticus (SE) and its subtypes.We compared and contrasted the results of four different efficacy criteria for the effectiveness of phenytoin, valproate, levetiracetam, and lacosamide. Criterion 1=

Seguir leyendo →
0

Health service provision for people with epilepsy in sub-Saharan Africa: A situational review

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Musa M. Watila, Mark R. Keezer, Samuel A. Angwafor, Andrea S. Winkler, Josemir W. Sander

Background
Epilepsy is a public health issue in sub-Saharan Africa (SSA) where many people with the condition receive no treatment. Health-care services for epilepsy in this region have not been comprehensively assessed. We examined key features ...

Seguir leyendo →
0

Health service provision for people with epilepsy in sub-Saharan Africa: A situational review

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Musa M. Watila, Mark R. Keezer, Samuel A. Angwafor, Andrea S. Winkler, Josemir W. Sander

Background
Epilepsy is a public health issue in sub-Saharan Africa (SSA) where many people with the condition receive no treatment. Health-care services for epilepsy in this region have not been comprehensively assessed. We examined key features ...

Seguir leyendo →
0

History of surgery for temporal lobe epilepsy

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ali A. Asadi-Pooya, Cyrus Rostami
The history of epilepsy and its treatment goes back to ancient times when it included medicinal herbs, lifestyle modifications, and even surgery. Trepanation is considered the oldest surgical procedure for the treatment of epilepsy. The first series of temporal lobectomies for the treatment of drug-resistant epilepsy were reported by Penfield and ...

Seguir leyendo →
0

History of surgery for temporal lobe epilepsy

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ali A. Asadi-Pooya, Cyrus Rostami
The history of epilepsy and its treatment goes back to ancient times when it included medicinal herbs, lifestyle modifications, and even surgery. Trepanation is considered the oldest surgical procedure for the treatment of epilepsy. The first series of temporal lobectomies for the treatment of drug-resistant epilepsy were reported by Penfield and ...

Seguir leyendo →
0

Correlates of perceived stigma for people living with epilepsy: A meta-analysis

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ying Shi, Shouqi Wang, Jie Ying, Meiling Zhang, Pengcheng Liu, Huanhuan Zhang, Jiao Sun

Objective
Epilepsy, one of the most common, serious chronic neurological diseases, is accompanied by different levels of perceived stigma that affects people in almost all age groups. This stigma can negatively impact the ...

Seguir leyendo →
0

Correlates of perceived stigma for people living with epilepsy: A meta-analysis

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ying Shi, Shouqi Wang, Jie Ying, Meiling Zhang, Pengcheng Liu, Huanhuan Zhang, Jiao Sun

Objective
Epilepsy, one of the most common, serious chronic neurological diseases, is accompanied by different levels of perceived stigma that affects people in almost all age groups. This stigma can negatively impact the ...

Seguir leyendo →
0

The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?

Publication date: May 2017Source:Epilepsy & Behavior, Volume 70, Part A
Author(s): Ramses Ribot, Bichun Ouyang, Andres M. Kanner

Purpose
Depression and anxiety disorders in patients with epilepsy (PWE) remain under-recognized and under-treated, despite being the most common psychiatric co-morbidities. Selective serotonin re-uptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are considered first-line treatment for primary depression and anxiety disorders. We performed this study to investigate if ...

Seguir leyendo →
0
Página 3 de 13 12345...»